Home » Great Britain defends the AstraZeneca vaccine from doubts about efficacy

Great Britain defends the AstraZeneca vaccine from doubts about efficacy

by admin

LONDON. Europe’s proven skepticism of the Oxford-AstraZeneca Covid vaccine has also spread to the UK. Some English people are already starting to give up their vaccination. And then the British government and the country take the field to allay doubts and concerns.

London: “AstraZeneca vaccine effective and safe”. WHO: “No reason not to use it”

by our correspondent Antonello Guerrera


Prime Minister Boris Johnson said yesterday he would be “absolutely delighted” to receive the Oxford-AstraZeneca vaccine when his turn comes. Today, however, the Minister of Health, Matt Hancock, wrote a clear and unequivocal editorial in the tabloid “Sun”, stressing that the British vaccine, already administered in the United Kingdom in 11 million doses to its residents, is “100% safe. I want to reassure everyone: there is no link with cases of thrombosis, nor any evidence that it can cause these pathologies which unfortunately are natural phenomena: according to our data, cases of thrombosis have even occurred to a lesser extent among the vaccinated than the average of the population before the immunization campaign. And it’s not just me: the British drug agency Mhra says it, Ema says it, the World Health Organization confirms it. So I tell you: don’t refuse the vaccine, and take it safely. We are on track to return to normal ”.

Europe split by Sputnik, but Italy can move the needle in favor of the Russian vaccine

by our correspondent Alberto d’Argenio



See also  Miriam Segato, two women stopped in Paris for the scooter accident

But the national effort is such that, in the same hours, Camilla, the Duchess of Cornwall and wife of Crown Prince Charles, also publicly revealed that she had received the Oxford-AstraZeneca vaccine a few weeks ago. Even the British newspapers have clearly decided which side to take: if the conservative and brexiter “Daily Telegraph” today opens on the front page, with a hint of schadenfreude, on the “quarrels between EU leaders” over the Oxford vaccine, the most moderate ( and pro-European) “Financial Times”, in an editorial by the management, criticizes the hesitations of the European Union on administration: “Fears about side effects must not jeopardize the vaccination campaign in the EU. In addition to the risks, health authorities must consider the great benefits of vaccines ”.

EU, EU-Pfizer agreement to accelerate. AstraZeneca, Ema: “Benefits exceed side effects”

by our correspondent Alberto D’Argenio



Meanwhile, while Europe is increasingly engulfed, the United Kingdom continues to run on the administration of Pfizer vaccines (60% of the total approximately) and Oxford-AstraZeneca (40%): yesterday another 440 thousand injected doses, today the quota of 25 will be exceeded. millions of British residents who have received at least one dose since the start of the campaign and by the weekend, the total will exceed 50% of the adult population.

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy